Jefferies Financial Group announced today that it is the first private-sector company to support a newly established public-private consortium launched by the U.S. Dept. of Health & Human Services (HHS).
HHS launched the program last week, announcing that it joined with ApiJect Systems America to create a high-volume “surge” drug packaging solution in the U.S. by using the blow-fill-seal (BFS) process used in sterile manufacturing facilities. HHS awarded ApiJect up to $456 million for the research and development of the BFS pre-filled syringes and its network of manufacturing facilities.
Get the full story at our sister site, Pharmaceutical Processing World